Investigates the efficacy of olanzapine or Zyprexa in treating Parkinson's Disease (PD) patients with dementia. Complication of PD; Implications for PD management and caregivers; Properties of olanzapine.EBSCO_AspBrown University Geriatric Psychopharmacology Update...
Patients may develop severe sedation,coma, and or delirium after an injection of extended release olanzapine. Patients must be examined for 3 hours after receiving an injection. Olanzapine may increaseprolactinlevels. Increased prolactin levels may manifest as abnormal menstruation, sexual dysfunction, and...
Olanzapine is not approved for the treatment of patients with dementia-related psychosis . Intramuscular route(Powder for Suspension, Extended Release) Patients are at risk for severe sedation (including coma) or delirium after each injection and must be observed for at least 3 hours in a ...
Olanzapine may cause serious side effects such as an increased risk of death or stroke in elderly patients with dementia, a higher risk of suicide when taken with fluoxetine, metabolic changes, tardive dyskinesia, low blood pressure, and blood cell disorders. See the warnings below for a full ...
Important Safety Information and Indications LYBALVI may cause serious side effects, including increased risk of death in elderly people withdementia-relatedpsychosis. LYBALVI increases the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (...
olanzapine has also been reported to decrease overall treatment costs, despite the several-fold higher daily acquisition cost of the drug. Olanzapine treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than haloperidol, and to broadly the same ex...
摘要: Study Objectives. To compare the effects of risperidone and olanzapine on cognition in elderly patients with dementia and psychosis, and to compare the side effects of these drugs.Design. Single-blind, multicenter, observational study.
摘要: Althoughthecorefeatureofalltypesofdementiaisprogressivecognitivedisruption,mostdementedpatientsalsoexpressnoncognitivebehavioralproblemsThesenoncognitiveproblemsleadtopotentiallydevastatingdisabilities,andareoftenamajorcauseofstress,anxietyandconcernforcaregiversPsychotropicdrugsarefrequentlyusedtocontrolthesesymptoms,butthey...
atypicalantipsychoticssuch as olanzapine but is less common than with haloperidol.159Olanzapine is not approved for the treatment of patients with dementia-related psychosis and should be avoided in this patient population.157Other side effects includehyperglycemia, neuroleptic malignant syndrome, and...
AIM:To compare the efficacies and adverse reactions of olanzapine and risperidone in the treatment of behavioral and psychological symptoms of dementia(BPSD).METHODS:Sixty-seven patients were divided into two groups.Thirty-two patients of olanzapine group took olanzapine(4.1±s 1.8)mg-d~(-1),2.5...